CoChat

Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines

Skalska, Lenka, White, Robert E., Parker, Gillian A., Sinclair, Alison J., Paschos, Kostas, Allday, Martin J. · 2013 · PLoS Pathogens
Cited by 77

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003187

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 54

  1. AP Bracken, 2009, Polycomb group proteins: navigators of lineage pathways led astray in cancer, Nat Rev Cancer, 9, 773, 10.1038/nrc2736 · DOI · Paper page
  2. JA Simon, 2009, Mechanisms of polycomb gene silencing: knowns and unknowns, Nat Rev Mol Cell Biol, 10, 697, 10.1038/nrm2763 · DOI · Paper page
  3. LS Young, 2004, Epstein-Barr virus: 40 years on, Nat Rev Cancer, 4, 757, 10.1038/nrc1452 · DOI · Paper page
  4. GW Bornkamm, 2001, Molecular virology of Epstein-Barr virus, Philos Trans R Soc Lond B Biol Sci, 356, 437, 10.1098/rstb.2000.0781 · DOI
  5. R Touitou, 2001, Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C, J Virol, 75, 7749, 10.1128/JVI.75.16.7749-7755.2001 · DOI
  6. M Hickabottom, 2002, Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP), J Biol Chem, 277, 47197, 10.1074/jbc.M208116200 · DOI
  7. GA Parker, 1996, Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7, Oncogene, 13, 2541
  8. JS Knight, 2005, SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen, Mol Cell Biol, 25, 1749, 10.1128/MCB.25.5.1749-1763.2005 · DOI
  9. JS Knight, 2005, Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase, Proc Natl Acad Sci U S A, 102, 18562, 10.1073/pnas.0503886102 · DOI · Paper page
  10. JS Knight, 2004, Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity, J Virol, 78, 1981, 10.1128/JVI.78.4.1981-1991.2004 · DOI
  11. BG Bajaj, 2008, Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein, J Virol, 82, 4082, 10.1128/JVI.02500-07 · DOI
  12. A Saha, 2009, Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2, J Virol, 83, 4652, 10.1128/JVI.02408-08 · DOI
  13. F Yi, 2009, Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities, Virology, 388, 236, 10.1016/j.virol.2009.03.027 · DOI
  14. T Choudhuri, 2007, The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block, J Virol, 81, 6718, 10.1128/JVI.00053-07 · DOI
  15. A Saha, 2011, EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5, J Virol, 85, 2079, 10.1128/JVI.02279-10 · DOI
  16. A Saha, 2012, E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells, PLoS Pathogens, 8, e1002573, 10.1371/journal.ppat.1002573 · DOI
  17. E Anderton, 2008, Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma, Oncogene, 27, 421, 10.1038/sj.onc.1210668 · DOI · Paper page
  18. K Paschos, 2009, Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim, PLoS Pathogens, 5, e1000492, 10.1371/journal.ppat.1000492 · DOI · Paper page
  19. L Skalska, 2010, Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP, PLoS Pathogens, 6, e1000951, 10.1371/journal.ppat.1000951 · DOI · Paper page
  20. RE White, 2010, Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification, PloS One, 5, e13979, 10.1371/journal.pone.0013979 · DOI
  21. RE White, 2012, EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors, The Journal of Clinical Investigation, 122, 1487, 10.1172/JCI58092 · DOI · Paper page
  22. K Paschos, 2012, BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV, Nucleic Acids Research, 40, 7233, 10.1093/nar/gks391 · DOI
  23. MJ McClellan, 2012, Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements, J Virol, 86, 5165, 10.1128/JVI.07161-11 · doi:10.1128/jvi.07161-11
  24. ML Hertle, 2009, Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes, PLoS Pathogens, 5, e1000506, 10.1371/journal.ppat.1000506 · DOI
  25. B Zhao, 2011, Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines, Proc Nat Acad Sci USA, 108, 337, 10.1073/pnas.1017419108 · DOI
  26. S Maruo, 2011, Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression, Proc Nat Acad Sci USA, 108, 1919, 10.1073/pnas.1019599108 · DOI
  27. BE Bernstein, 2006, A bivalent chromatin structure marks key developmental genes in embryonic stem cells, Cell, 125, 315, 10.1016/j.cell.2006.02.041 · DOI · Paper page
  28. NA Gruis, 1995, Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds, Nature Genetics, 10, 351, 10.1038/ng0795-351 · DOI · Paper page
  29. MJ Hayes, 2004, p16(INK4A)-independence of Epstein-Barr virus-induced cell proliferation and virus latency, The Journal of General Virology, 85, 1381, 10.1099/vir.0.79831-0 · DOI
  30. S Maruo, 2006, Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells, Proc Natl Acad Sci U S A, 103, 19500, 10.1073/pnas.0604919104 · DOI · Paper page
  31. M Muramatsu, 2000, Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme, Cell, 102, 553, 10.1016/S0092-8674(00)00078-7 · DOI · Paper page
  32. AP Bracken, 2004, E2F target genes: unraveling the biology, Trends in Biochemical Sciences, 29, 409, 10.1016/j.tibs.2004.06.006 · DOI · Paper page
  33. Q Cai, 2011, Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis, PLoS Pathogens, 7, e1002418, 10.1371/journal.ppat.1002418 · DOI
  34. J O'Nions, 2006, Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53, J Virol, 80, 12408, 10.1128/JVI.01363-06 · DOI
  35. MJ Allday, 1994, Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells, J Virol, 68, 3491, 10.1128/JVI.68.6.3491-3498.1994 · DOI
  36. E Heath, 2012, Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology, PLoS Pathogens, 8, e1002697, 10.1371/journal.ppat.1002697 · DOI
  37. MJ Allday, 1989, Epstein-Barr virus latent gene expression during the initiation of B cell immortalization, The Journal of General Virology, 70, 1755, 10.1099/0022-1317-70-7-1755 · DOI
  38. AJ Sinclair, 1994, EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus, The EMBO Journal, 13, 3321, 10.1002/j.1460-2075.1994.tb06634.x · DOI · Paper page
  39. LC Spender, 1999, Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus, J Virol, 73, 4678, 10.1128/JVI.73.6.4678-4688.1999 · DOI
  40. PA Nikitin, 2010, An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells, Cell Host & Microbe, 8, 510, 10.1016/j.chom.2010.11.004 · DOI · Paper page
  41. A Strasser, 2005, The role of BH3-only proteins in the immune system, Nat Rev Immunol, 5, 189, 10.1038/nri1568 · DOI · Paper page
  42. E Kashuba, 2003, EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells, International Journal of Cancer, 105, 644, 10.1002/ijc.11124 · DOI
  43. DA Thorley-Lawson, 2001, Epstein-Barr virus: exploiting the immune system, Nat Rev Immunol, 1, 75, 10.1038/35095584 · DOI · Paper page
  44. U Klangby, 1998, p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma, Blood, 91, 1680, 10.1182/blood.V91.5.1680 · DOI
  45. E Nagy, 2005, Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines, Anticancer Research, 25, 2153
  46. JA Richter-Larrea, 2010, Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma, Blood, 116, 2531, 10.1182/blood-2010-02-268003 · DOI · Paper page
  47. J O'Nions, 2003, Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2, Oncogene, 22, 7181, 10.1038/sj.onc.1206838 · DOI
  48. HJ Delecluse, 1998, Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells, Proc Natl Acad Sci U S A, 95, 8245, 10.1073/pnas.95.14.8245 · DOI · Paper page
  49. F Shaku, 2005, Development of a monoclonal antibody against Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) that can detect EBNA-LP expressed in P3HR1 cells, Microbiology and Immunology, 49, 477, 10.1111/j.1348-0421.2005.tb03743.x · doi:10.1111/j.1348-0421.2005.tb03743.x
  50. SK Kia, 2008, SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus, Mol Cell Biol, 28, 3457, 10.1128/MCB.02019-07 · DOI · Paper page
  51. E Turro, 2010, MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays, Nucleic Acids Research, 38, e4, 10.1093/nar/gkp853 · DOI
  52. T Yates, 2008, X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis, Nucleic Acids Research, 36, D780, 10.1093/nar/gkm779 · DOI
  53. MJ Okoniewski, 2007, An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data, Genome Biology, 8, R79, 10.1186/gb-2007-8-5-r79 · doi:10.1186/gb-2007-8-5-r79
  54. C Eisenhart, 1947, The assumptions underlying the analysis of variance, Biometrics, 3, 1, 10.2307/3001534 · DOI · Paper page

Cited by

See all 77

Metadata

Authors
Skalska, L., White, R. E., Parker, G. A., Sinclair, A. J., Paschos, K., & Allday, M. J.
Venue
PLoS Pathogens
Published
2013-02-21
Volume
9
Issue
2
Pages
e1003187
ISSN
1553-7374
Cited by
77
References
13
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines. https://app.cochat.ai/papers/10.1371/journal.ppat.1003187
The paper
Skalska, L., White, R. E., Parker, G. A., Sinclair, A. J., Paschos, K., & Allday, M. J. (2013). Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1003187

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.